LifeX Ventures already has 12 startups in its portfolio (nine US and three European) and plans to raise this figure to a maximum of 45. For...
The objective of advanced home telecare is to improve the quality of life of the elderly, ensuring intervention when they have a personal, social, or medical...
Biointaxis has received more than €2 million from the Center for Industrial Technological Development (Cdti), a public business entity whose objective is to promote innovation and...
Trea Healthcare Ventures will focus on around twenty-25 companies and will have an investment portfolio that can be common, preferred, Safe (Simple Agreements for Future Equity) shares, as well...
The six listed pharmaceutical companies closed the first quarter with a stock market value of €9.5 billion, compared to €10.6 billion at the close of the...
Vall d'Hebron is one of the main public hospitals in Spain. The center received 1.1 million outpatient visits (115,422 more than in 2020), more than 180,600...
Vytrus Biotech closed 2022 with a capitalization of more than €24 million, an increase of 98% since its debut on BME Growth, the SME stock market,...
Thanks to this investment plan, Novartis Italia, which already achieved a turnover of €1.72 billion in 2022, €78 million of which was obtained through exports, further...
Moderna closed 2022 with a profit of $8.36 billion, which represents a decrease of 31% compared to the previous year. Moderna argues this decrease to the...
Eniax also works with some medical centers in Spain, such as the HLA Moncloa University Hospital in Madrid, from Grupo Asisa. Another example of Eniax integration is...